Advertisement

Tumor Biology

, Volume 37, Issue 2, pp 2015–2021 | Cite as

∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299

  • Elisa Caiola
  • Eleonora Marrazzo
  • Simona Alesci
  • Massimo Broggini
  • Mirko Marabese
Original Article
  • 144 Downloads

Abstract

Caveolins have recently attracted attention for their possible involvement in signal transduction. Their role in cancer is debated, being reported both a suppressive and oncogenic role in different experimental conditions. Caveolin-1 is regulated by the tumor suppressor p53 which is able to bind its promoter and activate transcription. We had previous evidences indicating that a specific p73 isoform, namely ∆Np73β, when overexpressed in NCI-H1299 induced growth arrest and cell death. By gene expression analysis in cell transiently overexpressed with ∆Np73β, a strong induction of caveolin-1 was found. Caveolin was induced both at mRNA and protein level, and we characterised the promoter sequence of the gene encoding for caveolin-1 and found that the promoter region containing the putative p53 (and hence p73) binding sequence was responsive to ∆Np73β, but not to ∆Np73α and ∆Np73γ which do not induce growth arrest as ∆Np73β does. A reduction in cell adhesion was observed in ∆Np73β overexpressing cells, again supporting a possible role of caveolins in determining these effects. By using specific siRNA directed against human caveolin-1, we could not however antagonize the effects induced by ∆Np73β. Although caveolin-1 represents one of the genes whose expression is strongly activated by ∆Np73β, we could not define a role of caveolin-1 as a mediator of ∆Np73β associated growth arrest. It could well be that the expression of caveolin-1 is able to mediate other activities of ∆Np73β, and studies are in progress to determine whether its expression is mainly associated to metastatic spread.

Keywords

Caveolin-1 cav-1 p73 ∆Np73 Lung NSCLC 

Notes

Acknowledgments

The generous contribution of Alpe Burki-Macugnaga is gratefully acknowledged. The authors would like to dedicate this work to the memory of Dr. Maria Antonietta Sabatino, a very talented and motivated scientist, as well as a very good friend, who unfortunately passed away at very young age.

Conflicts on interest

None

Supplementary material

13277_2015_4012_MOESM1_ESM.jpg (196 kb)
ESM 1 (JPEG 195 kb)
13277_2015_4012_Fig7_ESM.gif (30 kb)
ESM 2

(GIF 30 kb)

13277_2015_4012_MOESM2_ESM.tif (192 kb)
High resolution image (TIFF 192 kb)

References

  1. 1.
    Fridolfsson HN, Roth DM, Insel PA, Patel HH. Regulation of intracellular signaling and function by caveolin. FASEB J. 2014;28(9):3823–31.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Hehlgans S, Cordes N. Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res. 2011;1:521–30.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Chidlow Jr JH, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res. 2010;86:219–25.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 2007;67:2849–56.CrossRefPubMedGoogle Scholar
  5. 5.
    Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 map kinase cascade. EMBO J. 1998;17:6633–48.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-src activity and met signaling. Cancer Res. 2007;67:7675–85.CrossRefPubMedGoogle Scholar
  7. 7.
    Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol. 2002;161:1647–56.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Li M, Chen H, Diao L, Zhang Y, Xia C, Yang F. Caveolin-1 and vegf-c promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori. 2010;96:734–43.PubMedGoogle Scholar
  9. 9.
    Wang R, Li Z, Guo H, Shi W, Xin Y, Chang W, et al. Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer bt474 cells. Mol Med Rep. 2014;9:1723–8.PubMedGoogle Scholar
  10. 10.
    Yu X, Riley T, Levine AJ. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009;276:2201–12.CrossRefPubMedGoogle Scholar
  11. 11.
    Marrazzo E, Marchini S, Tavecchio M, Alberio T, Previdi S, Erba E, et al. The expression of the deltanp73beta isoform of p73 leads to tetraploidy. Eur J Cancer. 2009;45:443–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Vikhanskaya F, Clerico L, Valenti M, Stanzione MS, Broggini M, Parodi S, et al. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53. Int J Cancer. 1997;72:155–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Marabese M, Mazzoletti M, Vikhanskaya F, Broggini M. Htra2 enhances the apoptotic functions of p73 on bax. Cell Death Differ. 2008;15:849–58.CrossRefPubMedGoogle Scholar
  14. 14.
    Marabese M, Vikhanskaya F, Broggini M. P73: a chiaroscuro gene in cancer. Eur J Cancer. 2007;43:1361–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Nunez-Wehinger S, Ortiz RJ, Diaz N, Diaz J, Lobos-Gonzalez L, Quest AF. Caveolin-1 in cell migration and metastasis. Curr Mol Med. 2014;14:255–74.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhang H, Su L, Muller S, Tighiouart M, Xu Z, Zhang X, et al. Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer. 2008;99:1684–94.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, et al. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res. 2011;71:4932–43.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, et al. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. Cell Cycle. 2013;12:1510–20.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Brodie SA, Lombardo C, Li G, Kowalski J, Gandhi K, You S, et al. Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced nsclc. PLoS One. 2014;9:e107124.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Pancotti F, Roncuzzi L, Maggiolini M, Gasperi-Campani A. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of stat3 signaling. Cell Signal. 2012;24:1390–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, et al. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous e-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle. 2011;10:3692–700.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Chunhacha P, Chanvorachote P. Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int J Physiol Pathophysiol Pharmacol. 2012;4:149–55.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Chunhacha P, Pongrakhananon V, Rojanasakul Y, Chanvorachote P. Caveolin-1 regulates mcl-1 stability and anoikis in lung carcinoma cells. Am J Physiol Cell Physiol. 2012;302:C1284–92.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Halim H, Luanpitpong S, Chanvorachote P. Acquisition of anoikis resistance up-regulates caveolin-1 expression in human non-small cell lung cancer cells. Anticancer Res. 2012;32:1649–58.PubMedGoogle Scholar
  25. 25.
    Wang Z, Wang N, Li W, Liu P, Chen Q, Situ H, et al. Caveolin-1 mediates chemoresistance in breast cancer stem cells via beta-catenin/abcg2 signaling pathway. Carcinogenesis. 2014;35:2346–56.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Laboratory of Molecular PharmacologyIRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”MilanItaly

Personalised recommendations